What is LOPJLB’s current signal on MRKR?

LOPJLB’s latest quantitative signal on Marker Therapeutics, Inc. (MRKR) is BUY in a RECOVERY regime. Signals are updated daily.

What market regime is MRKR in?

Marker Therapeutics, Inc. (MRKR) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Marker Therapeutics, Inc. (MRKR) do?

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary Mul…

Where is Marker Therapeutics, Inc. based / listed?

Marker Therapeutics, Inc. is based in US, listed on NASDAQ.

Marker Therapeutics, Inc. (MRKR) Stock · BUY · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $16M
Avg volume: 65.0K
Beta: 1.51
P/E (TTM): -3.13

Short % float: 1.49%
Days to cover: 3.6
SI change: -4.1%

1W: +29.31%
1M: +22.95%
3M: +7.14%
YTD: -2.60%

vs SPY 1W: +30.50%
vs SPY 1M: +19.63%
vs SPY 3M: +4.75%
vs SPY YTD: -14.35%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Marker Therapeutics, Inc. (MRKR)

Key stats

Sector peers

Prediction markets

EARNINGS HISTORY

Company news